Xenobiotic effects on ovarian preantral follicles

Biology of Reproduction

Volumn 85, Issue 5, 2011, Pages 871-883

  Mark Kappeler, Connie J ^a   Hoyer, Patricia B ^a   Devine, Patrick J ^b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b INRS INSTITUT ARMAND FRAPPIER   (Canada)

Author keywords

Atresia; Fertility; Follicle; Ovary; Toxicity; Toxicology

Indexed keywords

1,3 BUTADIENE; 2 BROMOPROPANE; 3 METHYLCHOLANTHRENE; 4,4' ISOPROPYLIDENEDIPHENOL; BONE MORPHOGENETIC PROTEIN; BUSULFAN; BUTADIENE DIEPOXIDE; CISPLATIN; CYCLOPHOSPHAMIDE; DIETHYLSTILBESTROL; DIMETHYLBENZ[A]ANTHRACENE; ENDOCRINE DISRUPTOR; GENISTEIN; KERATINOCYTE GROWTH FACTOR; LEUKEMIA INHIBITORY FACTOR; NERVE GROWTH FACTOR; PHOSPHORAMIDE MUSTARD; PLATELET DERIVED GROWTH FACTOR; POLYCYCLIC AROMATIC HYDROCARBON; STEM CELL FACTOR; XENOBIOTIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; CARCINOGENESIS; CHRONIC MYELOID LEUKEMIA; CIGARETTE SMOKING; CONTROLLED STUDY; DNA ADDUCT; DNA CROSS LINKING; DNA DAMAGE; FEMALE; FEMALE INFERTILITY; INTRACELLULAR SIGNALING; IONIZING RADIATION; MALE INFERTILITY; NONHUMAN; OCCUPATIONAL EXPOSURE; OVARIAN RESERVE; OVARY FOLLICLE DEVELOPMENT; OVARY FUNCTION; PRIORITY JOURNAL; RAT; REPRODUCTIVE TOXICITY; SHORT SURVEY; SINGLE DRUG DOSE;

ANIMALS; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; MENSTRUAL CYCLE; MODELS, ANIMAL; OCCUPATIONAL EXPOSURE; OVARIAN FOLLICLE; OVARY; RATS; XENOBIOTICS;

RATTUS; RODENTIA;

EID: 81055126933     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.111.091173     Document Type: Short Survey

References (183)

1. Ying Y, Zhao GQ. Cooperation of endoderm-derived BMP2 and extraembryonic ectoderm-derived BMP4 in primordial germ cell generation in the mouse. Dev Biol 2001; 232:484-492.
2. Ying Y, Qi X, Zhao GQ. Induction of primordial germ cells from murine epiblasts by synergistic action of BMP4 and BMP8B signaling pathways. Proc Natl Acad Sci U S A 2001; 98:7858-7862.
3. Ohinata Y, Ohta H, Shigeta M, Yamanaka K, Wakayama T, Saitou M. A signaling principle for the specification of the germ cell lineage in mice. Cell 2009; 137:571-584.
4. Merchant H, Zamboni L. Presence of connections between follicles in juvenile mouse ovaries. Am J Anat 1972; 134:127-132.
5. Pepling ME, de Cuevas M, Spradling AC. Germline cysts: a conserved phase of germ cell development? Trends Cell Biol 1999; 9:257-262.
6. Pepling ME, Spradling AC. Female mouse germ cells form synchronously dividing cysts. Development 1998; 125:3323-3328.
7. Pepling ME, Spradling AC. Mouse ovarian germ cell cysts undergo programmed breakdown to form primordial follicles. Dev Biol 2001; 234:339-351.
8. Gomperts M, Wylie C, Heasman J. Primordial germ cell migration. Ciba Found Symp 1994; 182:121-134.
9. Mazaud S, Guyot R, Guigon CJ, Coudouel N, Le Magueresse-Battistoni B, Magre S. Basal membrane remodeling during follicle histogenesis in the rat ovary: contribution of proteinases of the MMP and PA families. Dev Biol 2005; 277:403-416.
10. Sawyer HR, Smith P, Heath DA, Juengel JL, Wakefield SJ, McNatty KP. Formation of ovarian follicles during fetal development in sheep. Biol Reprod 2002; 66:1134-1150.
11. Bristol-Gould SK, Kreeger PK, Selkirk CG, Kilen SM, Mayo KE, Shea LD, Woodruff TK. Fate of the initial follicle pool: empirical and mathematical evidence supporting its sufficiency for adult fertility. Dev Biol 2006; 298:149-154.
12. Hirshfield AN. Heterogeneity of cell populations that contribute to the formation of primordial follicles in rats. Biol Reprod 1992; 47:466-472.
13. Baker TG. A quantitative and cytological study of germ cells in human ovaries. Proc R Soc Lond B Biol Sci 1963; 158:417-433.
14. Peters H, Himelstein-Braw R, Faber M. The normal development of the ovary in childhood. Acta Endocrinol (Copenh) 1976; 82:617-630.
15. Skinner MK. Regulation of primordial follicle assembly and development. Hum Reprod Update 2005; 11:461-471.
16. Hirshfield AN. Development of follicles in the mammalian ovary. Int Rev Cytol 1991; 124:43-101.
17. Wagenen GV, Simpson ME. Embryology of the Ovary and Testis Homo sapiens and Macaca mulatta. New Haven: Yale University Press; 1965.
18. Gougeon A. Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr Rev 1996; 17:121-155.
19. McGee EA, Hsu SY, Kaipia A, Hsueh AJ. Cell death and survival during ovarian follicle development. Mol Cell Endocrinol 1998; 140:15-18.
20. Tingen CM, Bristol-Gould SK, Kiesewetter SE, Wellington JT, Shea L, Woodruff TK. Prepubertal primordial follicle loss in mice is not due to classical apoptotic pathways. Biol Reprod 2009; 81:16-25.
21. Perez GI, Robles R, Knudson CM, Flaws JA, Korsmeyer SJ, Tilly JL. Prolongation of ovarian lifespan into advanced chronological age by Bax-deficiency. Nat Genet 1999; 21:200-203.
22. Bergeron L, Perez GI, Macdonald G, Shi L, Sun Y, Jurisicova A, Varmuza S, Latham KE, Flaws JA, Salter JC, Hara H, Moskowitz MA, Li E, Greenberg A, Tilly JL, Yuan J. Defects in regulation of apoptosis in caspase-2-deficient mice. Genes Dev 1998; 12:1304-1314.
23. Flaws JA, Hirshfield AN, Hewitt JA, Babus JK, Furth PA. Effect of bcl-2 on the primordial follicle endowment in the mouse ovary. Biol Reprod 2001; 64:1153-1159.
24. Ratts VS, Flaws JA, Kolp R, Sorenson CM, Tilly JL. Ablation of bcl-2 gene expression decreases the numbers of oocytes and primordial follicles established in the post-natal female mouse gonad. Endocrinology 1995; 136:3665-3668.
25. Baker TG, Franchi LL. The fine structure of oogonia and oocytes in the rhesus monkey (Macaca mulatta). Z Zellforsch Mikrosk Anat 1972; 126:53-74.
26. Faddy MJ, Gosden RG, Gougeon A, Richardson SJ, Nelson JF. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod 1992; 7:1342-1346.
27. Braw-Tal R, Roth Z. Gene expression for LH receptor, 17 alpha-hydroxylase and StAR in the theca interna of preantral and early antral follicles in the bovine ovary. Reproduction 2005; 129:453-461.
28. Campbell BK, Telfer EE, Webb R, Baird DT. Evidence of a role for follicle-stimulating hormone in controlling the rate of preantral follicle development in sheep. Endocrinology 2004; 145:1870-1879.
29. Silva JR, Van den Hurk R, de Matos MH, dos Santos RR, Pessoa C, de Moraes MO, de Figueiredo JR. Influences of FSH and EGF on primordial follicles during in vitro culture of caprine ovarian cortical tissue. Theriogenology 2004; 61:1691-1704.
30. Wandji SA, Srsen V, Voss AK, Eppig JJ, Fortune JE. Initiation in vitro of growth of bovine primordial follicles. Biol Reprod 1996; 55:942-948.
31. Devine PJ, Sipes IG, Skinner MK, Hoyer PB. Characterization of a rat in vitro ovarian culture system to study the ovarian toxicant 4-vinyl-cyclohexene diepoxide. Toxicol Appl Pharmacol 2002; 184:107-115.
32. Hutt KJ, McLaughlin EA, Holland MK. Kit ligand and c-Kit have diverse roles during mammalian oogenesis and folliculogenesis. Mol Hum Reprod 2006; 12:61-69.
33. Nilsson EE, Skinner MK. Kit ligand and basic fibroblast growth factor interactions in the induction of ovarian primordial to primary follicle transition. Mol Cell Endocrinol 2004; 214:19-25.
34. Nilsson EE, Detzel C, Skinner MK. Platelet-derived growth factor modulates the primordial to primary follicle transition. Reproduction 2006; 131:1007-1015.
35. Nilsson EE, Kezele P, Skinner MK. Leukemia inhibitory factor (LIF) promotes the primordial to primary follicle transition in rat ovaries. Mol Cell Endocrinol 2002; 188:65-73.
36. Kezele P, Nilsson EE, Skinner MK. Keratinocyte growth factor acts as a mesenchymal factor that promotes ovarian primordial to primary follicle transition. Biol Reprod 2005; 73:967-973.
37. Dole G, Nilsson EE, Skinner MK. Glial-derived neurotrophic factor promotes ovarian primordial follicle development and cell-cell interactions during folliculogenesis. Reproduction 2008; 135:671-682.
38. Nilsson EE, Skinner MK. Bone morphogenetic protein-4 acts as an ovarian follicle survival factor and promotes primordial follicle development. Biol Reprod 2003; 69:1265-1272.
39. Lee WS, Yoon SJ, Yoon TK, Cha KY, Lee SH, Shimasaki S, Lee S, Lee KA. Effects of bone morphogenetic protein-7 (BMP-7) on primordial follicular growth in the mouse ovary. Mol Reprod Dev 2004; 69:159-163.
40. Yu N, Roy SK. Development of primordial and prenatal follicles from undifferentiated somatic cells and oocytes in the hamster prenatal ovary in vitro: effect of insulin. Biol Reprod 1999; 61:1558-1567.
41. Kezele PR, Nilsson EE, Skinner MK. Insulin but not insulin-like growth factor-1 promotes the primordial to primary follicle transition. Mol Cell Endocrinol 2002; 192:37-43.
42. Dissen GA, Garcia-Rudaz C, Ojeda SR. Role of neurotrophic factors in early ovarian development. Semin Reprod Med 2009; 27:24-31.
43. Dissen GA, Romero C, Paredes A, Ojeda SR. Neurotrophic control of ovarian development. Microsc Res Tech 2002; 59:509-515.
44. Durlinger AL, Kramer P, Karels B, de Jong FH, Uilenbroek JT, Grootegoed JA, Themmen AP. Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary. Endocrinology 1999; 140:5789-5796.
45. Ding CC, Thong KJ, Krishna A, Telfer EE. Activin A inhibits activation of human primordial follicles in vitro. J Assist Reprod Genet 2010; 27:141-147.
46. Holt JE, Jackson A, Roman SD, Aitken RJ, Koopman P, McLaughlin EA. CXCR4/SDF1 interaction inhibits the primordial to primary follicle transition in the neonatal mouse ovary. Dev Biol 2006; 293:449-460.
47. Moore RK, Shimasaki S. Molecular biology and physiological role of the oocyte factor, BMP-15. Mol Cell Endocrinol 2005; 234:67-73.
48. Juengel JL, Bodensteiner KJ, Heath DA, Hudson NL, Moeller CL, Smith P, Galloway SM, Davis GH, Sawyer HR, McNatty KP. Physiology of GDF9 and BMP15 signalling molecules. Anim Reprod Sci 2004; 82-83:447-460.
49. Desmeules P, Devine PJ. Characterizing the ovotoxicity of cyclophosphamide metabolites on cultured mouse ovaries. Toxicol Sci 2006; 90:500-509.
50. Nilsson E, Parrott JA, Skinner MK. Basic fibroblast growth factor induces primordial follicle development and initiates folliculogenesis. Mol Cell Endocrinol 2001; 175:123-130.
51. Demeestere I, Centner J, Gervy C, Englert Y, Delbaere A. Impact of various endocrine and paracrine factors on in vitro culture of preantral follicles in rodents. Reproduction 2005; 130:147-156.
52. Li R, Phillips DM, Mather JP. Activin promotes ovarian follicle development in vitro. Endocrinology 1995; 136:849-856.
53. Liu X, Andoh K, Yokota H, Kobayashi J, Abe Y, Yamada K, Mizunuma H, Ibuki Y. Effects of growth hormone, activin, and follistatin on the development of preantral follicle from immature female mice. Endocrinology 1998; 139:2342-2347.
54. Smitz J, Cortvrindt R, Hu Y, Vanderstichele H. Effects of recombinant activin A on in vitro culture of mouse preantral follicles. Mol Reprod Dev 1998; 50:294-304.
55. McGee EA, Chun SY, Lai S, He Y, Hsueh AJ. Keratinocyte growth factor promotes the survival, growth, and differentiation of preantral ovarian follicles. Fertil Steril 1999; 71:732-738.
56. Reynaud K, Cortvrindt R, Smitz J, Driancourt MA. Effects of Kit Ligand and anti-Kit antibody on growth of cultured mouse preantral follicles. Mol Reprod Dev 2000; 56:483-494.
57. Hayashi M, McGee EA, Min G, Klein C, Rose UM, van DM, Hsueh AJ. Recombinant growth differentiation factor-9 (GDF-9) enhances growth and differentiation of cultured early ovarian follicles. Endocrinology 1999; 140:1236-1244.
58. Zhao J, Taverne MA, Van Der Weijden GC, Bevers MM, Van den Hurk R. Insulin-like growth factor-I (IGF-I) stimulates the development of cultured rat pre-antral follicles. Mol Reprod Dev 2001; 58:287-296.
59. Demeestere I, Gervy C, Centner J, Devreker F, Englert Y, Delbaere A. Effect of insulin-like growth factor-I during preantral follicular culture on steroidogenesis, in vitro oocyte maturation, and embryo development in mice. Biol Reprod 2004; 70:1664-1669.
60. Hooser SB, Douds DP, DeMerell DG, Hoyer PB, Sipes IG. Long-term ovarian and gonadotropin changes in mice exposed to 4-vinylcyclohexene. Reprod Toxicol 1994; 8:315-323.
61. Shuster LT, Gostout BS, Grossardt BR, Rocca WA. Prophylactic oophorectomy in premenopausal women and long-term health. Menopause Int 2008; 14:111-116.
62. Santen RJ, Allred DC, Ardoin SP, Archer DF, Boyd N, Braunstein GD, Burger HG, Colditz GA, Davis SR, Gambacciani M, Gower BA, Henderson VW, Jarjour WN, Karas RH, Kleerekoper M, Lobo RA, Manson JE, Marsden J, Martin KA, Martin L, Pinkerton JV, Rubinow DR, Teede H, Thiboutot DM, Utian WH. Postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab 2010; 95:s1-s66.
63. Byrne J. Long-term genetic and reproductive effects of ionizing radiation and chemotherapeutic agents on cancer patients and their offspring. Teratology 1999; 59:210-215.
64. Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update 2001; 7:535-543.
65. Chemaitilly W, Mertens AC, Mitby P, Whitton J, Stovall M, Yasui Y, Robison LL, Sklar CA. Acute ovarian failure in the childhood cancer survivor study. J Clin Endocrinol Metab 2006; 91:1723-1728.
66. Molina JR, Barton DL, Loprinzi CL. Chemotherapy-induced ovarian failure: manifestations and management. Drug Saf 2005; 28:401-416.
67. Sklar CA, Mertens AC, Mitby P, Whitton J, Stovall M, Kasper C, Mulder J, Green D, Nicholson HS, Yasui Y, Robison LL. Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study. J Natl Cancer Inst 2006; 98:890-896.
68. Himelstein-Braw R, Peters H, Faber M. Influence of irradiation and chemotherapy on the ovaries of children with abdominal tumours. Br J Cancer 1977; 36:269-275.
69. Nicosia SV, Matus-Riley M, Meadows AT. Gonadal effects of cancer therapy in girls. Cancer 1985; 55:2364-2372.
70. Larsen EC, Muller J, Schmiegelow K, Rechnitzer C, Andersen AN. Reduced ovarian function in long-term survivors of radiation-and chemotherapy-treated childhood cancer. J Clin Endocrinol Metab 2003; 88:5307-5314.
71. Lee CJ, Yoon YD. Gamma-radiation-induced follicular degeneration in the prepubertal mouse ovary. Mutat Res 2005; 578: 247-255.
72. Jarrell J, Younglai EV, Barr R, O'Connell G, Belbeck L, McMahon A. An analysis of the effects of increasing doses of ionizing radiation to the exteriorized rat ovary on follicular development, atresia, and serum gonadotropin levels. Am J Obstet Gynecol 1986; 154:306-309.
73. Pesty A, Doussau M, Lahaye JB, Lefevre B. Whole-body or isolated ovary (60)Co irradiation: effects on in vivo and in vitro folliculogenesis and oocyte maturation. Reprod Toxicol 2010; 29:93-98.
74. Ataya K, Pydyn E, Ramahi-Ataya A, Orton CG. Is radiation-induced ovarian failure in rhesus monkeys preventable by luteinizing hormone-releasing hormone agonists?: preliminary observations. J Clin Endocrinol Metab 1995; 80:790-795.
75. Adriaens I, Smitz J, Jacquet P. The current knowledge on radiosensitivity of ovarian follicle development stages. Hum Reprod Update 2009; 15:359-377.
76. Wallace WH, Thomson AB, Kelsey TW. The radiosensitivity of the human oocyte. Hum Reprod 2003; 18:117-121.
77. Sklar C. Maintenance of ovarian function and risk of premature menopause related to cancer treatment. J Natl Cancer Inst Monogr 2005; 34:25-27.
78. Thibaud E, Rodriguez-Macias K, Trivin C, Esperou H, Michon J, Brauner R. Ovarian function after bone marrow transplantation during childhood. Bone Marrow Transplant 1998; 21:287-290.
79. Green DM, Kawashima T, Stovall M, Leisenring W, Sklar CA, Mertens AC, Donaldson SS, Byrne J, Robison LL. Fertility of female survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol 2009; 27:2677-2685.
80. Wallace WH, Anderson RA, Irvine DS. Fertility preservation for young patients with cancer: who is at risk and what can be offered? Lancet Oncol 2005; 6:209-218.
81. Wallace WH, Thomson AB, Saran F, Kelsey TW. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys 2005; 62:738-744.
82. Davis VJ. Female gamete preservation. Cancer 2006; 107:1690-1694.
83. Stroud JS, Mutch D, Rader J, Powell M, Thaker PH, Grigsby PW. Effects of cancer treatment on ovarian function. Fertil Steril 2009; 92:417-427.
84. Wallace WH, Shalet SM, Crowne EC, Morris-Jones PH, Gattamaneni HR, Price DA. Gonadal dysfunction due to cis-platinum. Med Pediatr Oncol 1989; 17:409-413.
85. Yeh J, Kim B, Liang YJ, Peresie J. Mullerian inhibiting substance as a novel biomarker of cisplatin-induced ovarian damage. Biochem Biophys Res Commun 2006; 348:337-344.
86. Kociba RJ, Sleight SD. Acute toxicologic and pathologic effects of cis-diamminedichloroplatinum (NSC-119875) in the male rat. Cancer Chemother Rep 1971; 55:1-8.
87. Yucebilgin MS, Terek MC, Ozsaran A, Akercan F, Zekioglu O, Isik E, Erhan Y. Effect of chemotherapy on primordial follicular reserve of rat: an animal model of premature ovarian failure and infertility. Aust N Z J Obstet Gynaecol 2004; 44:6-9.
88. Borovskaya TG, Goldberg VE, Fomina TI, Pakhomova AV, Kseneva SI, Poluektova ME, Goldberg ED. Morphological and functional state of rat ovaries in early and late periods after administration of platinum cytostatics. Bull Exp Biol Med 2004; 137:331-335.
89. Generoso W, Stout SK, Huff SW. Effects of alkylating chemicals on reproductive capacity of adult female mice. Mutat Res 1971; 13:171-184.
90. Sakurada Y, Kudo S, Iwasaki S, Miyata Y, Nishi M, Masumoto Y. Collaborative work on evaluation of ovarian toxicity. 5) Two-or four-week repeated-dose studies and fertility study of busulfan in female rats. J Toxicol Sci 2009; 34(suppl 1):SP65-SP72.
91. Tan SJ, Yeh YC, Shang WJ, Wu GJ, Liu JY, Chen CH. Protective effect of a gonadotropin-releasing hormone analogue on chemotherapeutic agent-induced ovarian gonadotoxicity: a mouse model. Eur J Obstet Gynecol Reprod Biol 2010; 149:182-185.
92. Meirow D. Reproduction post-chemotherapy in young cancer patients. Mol Cell Endocrinol 2000; 169:123-131.
93. Plowchalk DR, Mattison DR. Phosphoramide mustard is responsible for the ovarian toxicity of cyclophosphamide. Toxicol Appl Pharmacol 1991; 107:472-481.
94. Howell S, Shalet S. Gonadal damage from chemotherapy and radiotherapy. Endocrinol Metab Clin North Am 1998; 27:927-943.
95. Costa M, Colia D. Treating infertility in autoimmune patients. Rheumatology (Oxford) 2008; 47(suppl 3):iii38-iii41.
96. Manger K, Wildt L, Kalden JR, Manger B. Prevention of gonadal toxicity and preservation of gonadal function and fertility in young women with systemic lupus erythematosus treated by cyclophosphamide: the PREGO-Study. Autoimmun Rev 2006; 5:269-272.
97. Plowchalk DR, Mattison DR. Reproductive toxicity of cyclophosphamide in the C57BL/6N mouse: 1. Effects on ovarian structure and function. Reprod Toxicol 1992; 6:411-421.
98. Meirow D, Lewis H, Nugent D, Epstein M. Subclinical depletion of primordial follicular reserve in mice treated with cyclophosphamide: clinical importance and proposed accurate investigative tool. Hum Reprod 1999; 14:1903-1907.
99. Meirow D, Epstein M, Lewis H, Nugent D, Gosden RG. Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations. Hum Reprod 2001; 16:632-637.
100. Petrillo SK, Desmeules P, Truong TQ, Devine PJ. Detection of DNA damage in oocytes of small ovarian follicles following phosphoramide mustard exposures of cultured rodent ovaries in vitro. Toxicol Appl Pharmacol 2011; 253:94-102.
101. Colvin OM. An overview of cyclophosphamide development and clinical applications. Curr Pharm Des 1999; 5:555-560.
102. Ataya KM, Valeriote FA, Ramahi-Ataya AJ. Effect of cyclophosphamide on the immature rat ovary. Cancer Res 1989; 49:1660-1664.
103. Jick H, Porter J, Morrison AS. Relation between smoking and age of natural menopause. Report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. Lancet 1977; 1:1354-1355.
104. Everson RB, Sandler DP, Wilcox AJ, Schreinemachers D, Shore DL, Weinberg C. Effect of passive exposure to smoking on age at natural menopause. Br Med J (Clin Res Ed) 1986; 293:792.
105. Neal MS, Zhu J, Foster WG. Quantification of benzo[a]pyrene and other PAHs in the serum and follicular fluid of smokers versus non-smokers. Reprod Toxicol 2008; 25:100-106.
106. El-Nemr A, Al-Shawaf T, Sabatini L, Wilson C, Lower AM, Grudzinskas JG. Effect of smoking on ovarian reserve and ovarian stimulation in in-vitro fertilization and embryo transfer. Hum Reprod 1998; 13:2192-2198.
107. Weinberg CR, Wilcox AJ, Baird DD. Reduced fecundability in women with prenatal exposure to cigarette smoking. Am J Epidemiol 1989; 129:1072-1078.
108. Stedman RL. The chemical composition of tobacco and tobacco smoke. Chem Rev 1968; 68:153-207.
109. Tuttle AM, Stampfli M, Foster WG. Cigarette smoke causes follicle loss in mice ovaries at concentrations representative of human exposure. Hum Reprod 2009; 24:1452-1459.
110. Vahakangas K, Rajaniemi H, Pelkonen O. Ovarian toxicity of cigarette smoke exposure during pregnancy in mice. Toxicol Lett 1985; 25:75-80.
111. Mattison DR, Thorgeirsson SS. Ovarian aryl hydrocarbon hydroxylase activity and primordial oocyte toxicity of polycyclic aromatic hydrocarbons in mice. Cancer Res 1979; 39:3471-3475.
112. Borman SM, Christian PJ, Sipes IG, Hoyer PB. Ovotoxicity in female Fischer rats and B6 mice induced by low-dose exposure to three polycyclic aromatic hydrocarbons: comparison through calculation of an ovotoxic index. Toxicol Appl Pharmacol 2000; 167:191-198.
113. Mattison DR. Morphology of oocyte and follicle destruction by polycyclic aromatic hydrocarbons in mice. Toxicol Appl Pharmacol 1980; 53:249-259.
114. Mattison DR. Difference in sensitivity of rat and mouse primordial oocytes to destruction by polycyclic aromatic hydrocarbons. Chem Biol Interact 1979; 28:133-137.
115. Mattison DR, Shiromizu K, Nightingale MS. Oocyte destruction by polycyclic aromatic hydrocarbons. Am J Ind Med 1983; 4:191-202.
116. Rajapaksa KS, Sipes IG, Hoyer PB. Involvement of microsomal epoxide hydrolase enzyme in ovotoxicity caused by 7,12-dimethylbenz[a]anthracene. Toxicol Sci 2007; 96:327-334.
117. Igawa Y, Keating AF, Rajapaksa KS, Sipes IG, Hoyer PB. Evaluation of ovotoxicity induced by 7, 12-dimethylbenz[a]anthracene and its 3,4-diol metabolite utilizing a rat in vitro ovarian culture system. Toxicol Appl Pharmacol 2009; 234:361-369.
118. Matikainen T, Perez GI, Jurisicova A, Pru JK, Schlezinger JJ, Ryu HY, Laine J, Sakai T, Korsmeyer SJ, Casper RF, Sherr DH, Tilly JL. Aromatic hydrocarbon receptor-driven Bax gene expression is required for premature ovarian failure caused by biohazardous environmental chemicals. Nat Genet 2001; 28:355-360.
119. Jurisicova A, Taniuchi A, Li H, Shang Y, Antenos M, Detmar J, Xu J, Matikainen T, Benito Hernandez A, Nunez G, Casper RF. Maternal exposure to polycyclic aromatic hydrocarbons diminishes murine ovarian reserve via induction of Harakiri. J Clin Invest 2007; 117:3971-3978.
120. Neal MS, Mulligan Tuttle AM, Casper RF, Lagunov A, Foster WG. Aryl hydrocarbon receptor antagonists attenuate the deleterious effects of benzo[a]pyrene on isolated rat follicle development. Reprod Biomed Online 2010; 21:100-108.
121. IARC. IARC monographs on the evaluation of carcinogenic risks to humans. 1,3-butadiene, ethylene oxide and vinyl halides (vinyl fluoride, vinyl chloride and vinyl bromide). IARC Monogr Eval Carcinog Risks Hum 2008; 97:3-471.
122. Mumtaz MM, George JD, Gold KW, Cibulas W, Derosa CT. ATSDR evaluation of health effects of chemicals. IV. Polycyclic aromatic hydrocarbons (PAHs): understanding a complex problem. Toxicol Ind Health 1996; 12:742-995.
123. IARC (International Agency for Research on Cancer). IARC monographs on the evaluation of carcinogenic risks to humans: some industrial chemicals. Lyon, France: 1994.
124. Melnick RL, Huff J. 1,3-Butadiene: toxicity and carcinogenicity in laboratory animals and humans. Rev Environ Contam Toxicol 1992; 124:111-144.
125. Grant RL, Haney J, Curry AL, Honeycutt M. A chronic reference value for 1,3-butadiene based on an updated noncancer toxicity assessment. J Toxicol Environ Health B Crit Rev 2010; 13:460-475.
126. Hoyer PB, Sipes IG. Assessment of follicle destruction in chemical-induced ovarian toxicity. Annu Rev Pharmacol Toxicol 1996; 36:307-331.
127. National Toxicology Program. NTP toxicology and carcinogenesis studies of 1,3-butadiene (CAS No. 106-99-0) in B6C3F1 mice (inhalation studies). Natl Toxicol Program Tech Rep Ser 1993; 434:1-389.
128. Doerr JK, Hooser SB, Smith BJ, Sipes IG. Ovarian toxicity of 4-vinylcyclohexene and related olefins in B6C3F1 mice: role of diepoxides. Chem Res Toxicol 1995; 8:963-969.
129. Doerr JK, Hollis EA, Sipes IG. Species difference in the ovarian toxicity of 1,3-butadiene epoxides in B6C3F1 mice and Sprague-Dawley rats. Toxicology 1996; 113:128-136.
130. Hoyer PB, Sipes IG. Development of an animal model for ovotoxicity using 4-vinylcyclohexene: a case study. Birth Defects Res B Dev Reprod Toxicol 2007; 80:113-125.
131. Smith BJ, Mattison DR, Sipes IG. The role of epoxidation in 4-vinylcyclohexene-induced ovarian toxicity. Toxicol Appl Pharmacol 1990; 105:372-381.
132. Ito A, Mafune N, Kimura T. Collaborative work on evaluation of ovarian toxicity. 4) Two-or four-week repeated dose study of 4-vinylcyclohexene diepoxide in female rats. J Toxicol Sci 2009; 34(suppl 1): SP53-SP58.
133. Mayer LP, Pearsall NA, Christian PJ, Devine PJ, Payne CM, McCuskey MK, Marion SL, Sipes IG, Hoyer PB. Long-term effects of ovarian follicular depletion in rats by 4-vinylcyclohexene diepoxide. Reprod Toxicol 2002; 16:775-781.
134. National Toxicology Program. Toxicology and Carcinogenesis Studies of 4-vinyl-1-cyclohexene in F344/a Rats and B6C3F1 Mice (Gavage Studies). 303. Rockville, MD: National Institutes of Health; 1986.
135. National Toxicology Program. Toxicology and Carcinogenesis studies of 4-vinyl-1-cyclohexene diepoxide in F344/N Rats and B6C3F1 Mice. 362. Rockville, MD: National Institutes of Health; 1989.
136. Springer LN, McAsey ME, Flaws JA, Tilly JL, Sipes IG, Hoyer PB. Involvement of apoptosis in 4-vinylcyclohexene diepoxide-induced ovotoxicity in rats. Toxicol Appl Pharmacol 1996; 139:394-401.
137. Borman SM, VanDePol BJ, Kao A, Thompson KE, Sipes IG, Hoyer PB. A single dose of the ovotoxicant 4-vinylcyclohexene diepoxide is protective in rat primary ovarian follicles. Toxicol Appl Pharmacol 1999; 158:244-252.
138. Hu XM, Christian PJ, Thompson KE, Sipes IG, Hoyer PB. Apoptosis induced in rats by 4-vinylcyclohexene diepoxide is associated with activation of the caspase cascades. Biol Reprod 2001; 65:87-93.
139. Hu XM, Christian PJ, Sipes IG, Hoyer PB. Expression and redistribution of cellular bad, bax and bcl-xl protein is associated with VCD-induced ovotoxicity in rats. Biol Reprod 2001; 65:1489-1495.
140. Hu X, Flaws JA, Sipes IG, Hoyer PB. Activation of mitogen-activated protein kinases and AP-1 transcription factor in ovotoxicity induced by 4-vinylcyclohexene diepoxide in rats. Biol Reprod 2002; 67:718-724.
141. Fernandez SM, Keating AF, Christian PJ, Sen N, Hoying JB, Brooks HL, Hoyer PB. Involvement of the KIT/KITL signaling pathway in 4-vinylcyclohexene diepoxide-induced ovarian follicle loss in rats. Biol Reprod 2008; 79:318-327.
142. Ismail RS, Okawara Y, Fryer JN, Vanderhyden BC. Hormonal regulation of the ligand for c-kit in the rat ovary and its effects on spontaneous oocyte meiotic maturation. Mol Reprod Dev 1996; 43:458-469.
143. Liu K, Rajareddy S, Liu L, Jagarlamudi K, Boman K, Selstam G, Reddy P. Control of mammalian oocyte growth and early follicular development by the oocyte PI3 kinase pathway: new roles for an old timer. Dev Biol 2006; 299:1-11.
144. Keating AF, Mark CJ, Sen N, Sipes IG, Hoyer PB. Effect of phosphatidylinositol-3 kinase inhibition on ovotoxicity caused by 4-vinylcyclohexene diepoxide and 7, 12-dimethylbenz[a]anthracene in neonatal rat ovaries. Toxicol Appl Pharmacol 2009; 241:127-134.
145. Keating AF, Sen N, Sipes IG, Hoyer PB. Dual protective role for glutathione S-transferase class pi against VCD-induced ovotoxicity in the rat ovary. Toxicol Appl Pharmacol 2010; 247:71-75.
146. Boekelheide K, Darney SP, Daston GP, David RM, Luderer U, Olshan AF, Sanderson WT, Willhite CC, Woskie S. NTP-CERHR Expert Panel Report on the reproductive and developmental toxicity of 2-bromopropane. Reprod Toxicol 2004; 18:189-217.
147. Park J, Shin KS, Kim Y. Occupational reproductive function abnormalities and bladder cancer in Korea. J Korean Med Sci 2010; 25:S41-S45.
148. Kim Y, Jung K, Hwang T, Jung G, Kim H, Park J, Kim J, Park J, Park D, Park S, Choi K, Moon Y. Hematopoietic and reproductive hazards of Korean electronic workers exposed to solvents containing 2-bromopropane. Scand J Work Environ Health 1996; 22:387-391.
149. Koh JM, Kim CH, Hong SK, Lee KU, Kim YT, Kim OJ, Kim GS. Primary ovarian failure caused by a solvent containing 2-bromopropane. Eur J Endocrinol 1998; 138:554-556.
150. Kim Y, Park J, Moon Y. Hematopoietic and reproductive toxicity of 2-bromopropane, a recently introduced substitute for chlorofluorocarbons. Toxicol Lett 1999; 108:309-313.
151. Park J, Kim Y, Park D, Choi K, Park S, Moon Y. An outbreak of hematopoietic and reproductive disorders due to solvents containing 2-bromopropane in an electronic factory, South Korea: epidemiological survey. J Occup Health 1997; 39:138-143.
152. Takeuchi Y, Ichihara G, Kamijima M. A review of toxicity of 2-bromopropane: mainly on its reproductive toxicity. J Occup Health 1997; 39:191.
153. Kamijima M, Ichihara G, Kitoh J, Tsukamura H, Maeda M, Yu X, Xie Z, Nakajima T, Asaeda N, Hisanaga N, Takeuchi Y. Ovarian toxicity of 2-bromopropane in the non-pregnant female rat. J Occup Health 1997; 39:144-149.
154. Sekiguchi S, Asano G, Suda M, Honma T. Influence of 2-bromopropane on reproductive system-short-term administration of 2-bromopropane inhibits ovulation in F344 rats. Toxicol Ind Health 2001; 16:277-283.
155. Sekiguchi S, Suda M, Zhai YL, Honma T. Effects of 1-bromopropane, 2-bromopropane, and 1,2-dichloropropane on the estrous cycle and ovulation in F344 rats. Toxicol Lett 2002; 126:41-49.
156. Yu XZ, Kamijima M, Ichihara G, Li W, Kitoh J, Xie Z, Shibata E, Hisanaga N, Takeuchi Y. 2-Bromopropane causes ovarian dysfunction by damaging primordial follicles and their oocytes in female rats. Toxicol Appl Pharmacol 1999; 159:185-193.
157. Dobson RL, Felton JS. Female germ cell loss from radiation and chemical exposures. Am J Ind Med 1983; 4:175-190.
158. Uzumcu M, Zachow R. Developmental exposure to environmental endocrine disruptors: consequences within the ovary and on female reproductive function. Reprod Toxicol 2007; 23:337-352.
159. Brown A, Jolly P, Wei H. Genistein modulates neuroblastoma cell proliferation and differentiation through induction of apoptosis and regulation of tyrosine kinase activity and N-myc expression. Carcinogenesis 1998; 19:991-997.
160. Gu Y, Zhu CF, Iwamoto H, Chen JS. Genistein inhibits invasive potential of human hepatocellular carcinoma by altering cell cycle, apoptosis, and angiogenesis. World J Gastroenterol 2005; 11:6512-6517.
161. Han RM, Tian YX, Liu Y, Chen CH, Ai XC, Zhang JP, Skibsted LH. Comparison of flavonoids and isoflavonoids as antioxidants. J Agric Food Chem 2009; 57:3780-3785.
162. Kouki T, Kishitake M, Okamoto M, Oosuka I, Takebe M, Yamanouchi K. Effects of neonatal treatment with phytoestrogens, genistein and daidzein, on sex difference in female rat brain function: estrous cycle and lordosis. Horm Behav 2003; 44:140-145.
163. Nikaido Y, Yoshizawa K, Danbara N, Tsujita-Kyutoku M, Yuri T, Uehara N, Tsubura A. Effects of maternal xenoestrogen exposure on development of the reproductive tract and mammary gland in female CD-1 mouse offspring. Reprod Toxicol 2004; 18:803-811.
164. Jefferson W, Newbold R, Padilla-Banks E, Pepling M. Neonatal genistein treatment alters ovarian differentiation in the mouse: inhibition of oocyte nest breakdown and increased oocyte survival. Biol Reprod 2006; 74:161-168.
165. Jefferson W, Padilla-Banks E, Newbold RR. Disruption of the developing female reproductive system by phytoestogens: genistein as an example. Mol Nutr Food Res 2007; 51:832-844.
166. Jefferson WN, Couse JF, Padilla-Banks E, Korach KS, Newbold RR. Neonatal exposure to genistein induces estrogen receptor (ER)alpha expression and multioocyte follicles in the maturing mouse ovary: evidence for ERbeta-mediated and nonestrogenic actions. Biol Reprod 2002; 67:1285-1296.
167. Zhuang XL, Fu YC, Xu JJ, Kong XX, Chen ZG, Luo LL. Effects of genistein on ovarian follicular development and ovarian life span in rats. Fitoterapia 2010; 81: 998-1002.
168. Markey CM, Rubin BS, Soto AM, Sonnenschein C. Endocrine disruptors: from Wingspread to environmental developmental biology. J Steroid Biochem Mol Biol 2002; 83:235-244.
169. Burridge E. Bisphenol A: product profile. Eur Chem News 2003; 17:14-20.
170. Ikezuki Y, Tsutsumi O, Takai Y, Kamei Y, Taketani Y. Determination of bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure. Hum Reprod 2002; 17:2839-2841.
171. Schonfelder G, Wittfoht W, Hopp H, Talsness CE, Paul M, Chahoud I. Parent bisphenol A accumulation in the human maternal-fetal-placental unit. Environ Health Perspect 2002; 110:A703-A707.
172. Calafat AM, Kuklenyik Z, Reidy JA, Caudill SP, Ekong J, Needham LL. Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect 2005; 113:391-395.
173. Richter CA, Birnbaum LS, Farabollini F, Newbold RR, Rubin BS, Talsness CE, Vandenbergh JG, Walser-Kuntz DR, vom Saal FS. In vivo effects of bisphenol A in laboratory rodent studies. Reprod Toxicol 2007; 24:199-224.
174. Welshons WV, Nagel SC, vom Saal FS. Large effects from small exposures. III: endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology 2006; 147:S56-S69.
175. Rodriguez HA, Santambrosio N, Santamaria CG, Munoz-de-Toro M, Luque EH. Neonatal exposure to bisphenol A reduces the pool of primordial follicles in the rat ovary. Reprod Toxicol 2010; 30:550-557.
176. Suzuki A, Sugihara A, Uchida K, Sato T, Ohta Y, Katsu Y, Watanabe H, Iguchi T. Developmental effects of perinatal exposure to bisphenol-A and diethylstilbestrol on reproductive organs in female mice. Reprod Toxicol 2002; 16:107-116.
177. Hunt PA, Koehler KE, Susiarjo M, Hodges CA, Ilagan A, Voigt RC, Thomas S, Thomas BF, Hassold TJ. Bisphenol a exposure causes meiotic aneuploidy in the female mouse. Curr Biol 2003; 13:546-553.
178. Susiarjo M, Hassold TJ, Freeman E, Hunt PA. Bisphenol A exposure in utero disrupts early oogenesis in the mouse. PLoS Genet 2007; 3:66-70 (e5).
179. Newbold RR. Lessons learned from perinatal exposure to diethylstilbestrol. Toxicol Appl Pharmacol 2004; 199:142-150.
180. Sheehan DM, Young M. Diethylstilbestrol and estradiol binding to serum albumin and pregnancy plasma of rat and human. Endocrinology 1979; 104:1442-1446.
181. Newbold RR, Bullock BC, Mc Lachlan JA. Exposure to diethylstilbestrol during pregnancy permanently alters the ovary and oviduct. Biol Reprod 1983; 28:735-744.
182. Iguchi T, Fukazawa Y, Uesugi Y, Takasugi N. Polyovular follicles in mouse ovaries exposed neonatally to diethylstilbestrol in vivo and in vitro. Biol Reprod 1990; 43:478-484.
183. Iguchi T, Kamiya K, Uesugi Y, Sayama K, Takasugi N. In vitro fertilization of oocytes from polyovular follicles in mouse ovaries exposed neonatally to diethylstilbestrol. In Vivo 1991; 5:359-363.